학술논문
Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Immunogenicity and Reactogenicity.
Document Type
Article
Author
Source
Subject
*COVID-19 vaccines
*SERODIAGNOSIS
*PATIENTS
*TREATMENT effectiveness
*MESSENGER RNA
*DESCRIPTIVE statistics
*HEMATOPOIETIC stem cell transplantation
*TRANSPLANTATION of organs, tissues, etc.
*
*
*
*
*
*
*
Language
ISSN
1058-4838
Abstract
The severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine–induced humoral response and reactogenicity profile are described in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Findings showed that 75.0% (by Simoa assay) or 80.0% (by Roche assay) of the HSCT cohort had a positive antibody response on series completion, compared with 100% in the healthy cohort. [ABSTRACT FROM AUTHOR]